Herbas VPB

Print
EN | LT
LT - AN INHALABLE DRY POWDER FORMULATION COMPRISING GLP-1 FOR USE IN THE TREATMENT OF HYPERGLYCEMIA AND DIABETES BY PULMONARY ADMINISTRATION
EN - AN INHALABLE DRY POWDER FORMULATION COMPRISING GLP-1 FOR USE IN THE TREATMENT OF HYPERGLYCEMIA AND DIABETES BY PULMONARY ADMINISTRATION

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 9/14
A61K 31/495
A61K 38/26
A61P 3/10
European patent
(11) Number of the document 2211842
(13) Kind of document T
(96) European patent application number 08841194.7
Date of filing the European patent application 2008-10-24
(97) Date of publication of the European application 2010-08-04
(45) Date of publication and mention of the grant of the patent 2015-08-12
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2008/081218
Date 2008-10-24
PCT application publication
(87) Number WO 2009/055740
Date 2009-04-30
Priority applications
(30) Number Date Country code
982368 P 2007-10-24 US
985620 P 2007-11-05 US
33740 P 2008-03-04 US
52127 P 2008-05-09 US
Inventors
(72)
RICHARDSON, Peter, US
BAUGHMAN, Robert, A., US
COSTELLO, Donald, US
Grantee
(73) MannKind Corporation, 25134 Rye Canyon Loop, Valencia CA 91355, US
Title
(54) AN INHALABLE DRY POWDER FORMULATION COMPRISING GLP-1 FOR USE IN THE TREATMENT OF HYPERGLYCEMIA AND DIABETES BY PULMONARY ADMINISTRATION
  AN INHALABLE DRY POWDER FORMULATION COMPRISING GLP-1 FOR USE IN THE TREATMENT OF HYPERGLYCEMIA AND DIABETES BY PULMONARY ADMINISTRATION
Last update date 2021-04-30